McDermott and Bull executive Search
 

Other News

ELDORADO Selects AdaCore’s QGen for Critical Medical Applications

Rhythm by 0 comments

Model-based engineering toolsuite brings high reliability to medical device software NEW YORK & PARIS & CAMPINAS, Brazil–(BUSINESS WIRE)–AdaCore today announced that The ELDORADO Research Institute of Brazil (ELDORADO) has selected the QGen model-based code generation and verification toolsuite to support research and development of safety-critical medical device software. These applications […]

Continue Reading →

InspireMD Announces Planned Leadership Transition

Financial by 0 comments

Life sciences industry veteran Marvin Slosman appointed Chief Executive Officer   Appointment adds significant medical technology commercialization experience to the InspireMD team TEL AVIV, Israel, Dec. 10, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused […]

Continue Reading →

Orchestra BioMed™ Secures $20 Million Financing Facility from Silicon Valley Bank

Financial by 0 comments

NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, today announced that it has entered into a $20 million credit facility agreement with Silicon Valley Bank (SVB), the bank of the world’s most […]

Continue Reading →

Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess™ For Recent Onset Atrial Fibrillation

Financial Regulatory by 0 comments

NASDAQ: CORV   TSX: CORV VANCOUVER, Dec. 10, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that NASDAQ and the Toronto Stock Exchange (TSX) have halted trading of the Company’s common stock.  The U.S. Food and Drug Administration (FDA)’s Cardiovascular and Renal […]

Continue Reading →

Quantum Genomics and Biolab Sanus Pharmaceutical Enter into Exclusive Licensing and Collaboration Agreement for Firibastat in Latin America

Financial by 0 comments

Biolab Sanus Pharmaceutical to receive an exclusive license to develop and commercialize firibastat for the treatment of arterial hypertension in Latin America PARIS and NEW YORK, Dec. 09, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the […]

Continue Reading →

Cardiologs Earns Frost & Sullivan’s New Product Innovation Award

Rhythm by 0 comments

Cloud-based AI Technology Recognized for Providing Faster, More Accurate EKG Analysis PARIS and BOSTON, Dec. 9, 2019 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today it has earned global industry analysts Frost & Sullivan’s New Product Innovation Award. The pioneering cloud-based AI solution was recognized for its ability to analyze ambulatory […]

Continue Reading →

Windtree Therapeutics Completes $26.4 Million Private Placement

Financial by 0 comments

WARRINGTON, Pa., Dec. 9, 2019 /PRNewswire/ — Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that it has completed a $26.4 million private placement of common stock and warrants. In connection with this offering, […]

Continue Reading →

QuVa Pharma® Launches Cardioplegia Offering through a Compounding and Distribution Agreement with Hibernation Therapeutics for Adenocaine™ Solution

Coronary/Structural Heart by 0 comments

Access to improved Adenocaine™ solution, a ready to administer heart arrest and cardioprotection innovation, is immediately available to hospitals nationwide SUGAR LAND, Texas, Dec. 9, 2019 /PRNewswire/ — QuVa Pharma, Inc. today announced it has signed a production and distribution agreement with Hibernation Therapeutics for its patented cardioplegia solution Adenocaine™, the combination of […]

Continue Reading →

BioVentrix Announces Publication of Positive One-Year Outcomes for Revivent TC System

Coronary/Structural Heart by 0 comments

Study Published in European Journal of Heart Failure Shows Significant and Sustained Improvement in Heart Function, Symptom Relief and Quality of Life Using Less Invasive Left Ventricular Enhancement Device SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first less invasive system for left ventricular remodeling, today announced online publication of positive […]

Continue Reading →
1 2 3 … 325